STOCK TITAN

Borealis Foods Expands Access to Protein-Rich Chef Woo Noodles Through Costco

(Very Positive)
Tags

Borealis Foods (Nasdaq: BRLS) announced the launch of its Chef Woo High-Protein Noodles at Costco, noting strong early demand from members. According to Borealis Foods, retailer demand forecasts for its high-protein noodles are encouraging, and the company links rising interest to broader consumer shifts toward protein-rich, nutrient-dense meals influenced by increased GLP-1 weight-loss medication use.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

Market reaction after Costco product launch: BRLS -9.62% in the Jul 15 session

-9.62% 5.0x vol
11 alerts
-9.62% Session close to close
+2.9% Peak Tracked
-19.7% Trough Tracked
$21.46M Market Cap
5.0x Rel. Volume

In the Jul 15 session, BRLS declined 9.62%, reflecting a notable negative market reaction. Argus tracked a peak move of +2.9% during that session. Argus tracked a trough of -19.7% from its starting point during tracking. Our momentum scanner triggered 11 alerts that day, indicating notable trading interest and price volatility. Trading volume was exceptionally heavy at 5.0x the daily average, suggesting significant selling pressure.

Data tracked by StockTitan Argus on the day of publication.

Market Context

The stock moved -9.6% in the session following this news. A steep decline after the Costco launch co...
Analysis

The stock moved -9.6% in the session following this news. A steep decline after the Costco launch could reflect lingering concern from prior disclosures of going-concern risk and Nasdaq deficiency, despite earlier positive reactions of 7.49% and 67.26%, and might diverge from the stock’s tendency to rally on operational updates.

Key Figures

Protein per serving: 20 grams Essential amino acids: 9
2 metrics
Protein per serving 20 grams Chef Woo High-Protein Noodles nutritional profile
Essential amino acids 9 Chef Woo High-Protein Noodles nutritional profile

Historical Context

3 past events · Latest: Jul 10 (Positive)
Pattern 3 events
Date Event Sentiment 24h Move Catalyst
Jul 10 business update Positive +7.5% Q1 2026 revenue growth, margin improvement, and debt maturity extension.
Apr 28 refinancing deal Positive +67.3% New term loan to refinance Frontwell facility and support operations.
Apr 23 Nasdaq deficiency notice Negative +0.0% Delayed filing of fiscal 2025 Form 10-K and compliance timeline disclosure.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

Recent headlines on financing and operational progress have often coincided with positive price reactions.

Key Terms

glp-1, semaglutide, tirzepatide, liraglutide
4 terms
glp-1 medical
"Industry research indicates that increased use of GLP-1 medications, including"
GLP-1 (glucagon-like peptide-1) is a natural hormone in the body that helps regulate blood sugar levels and appetite. Its significance to investors lies in its role as the basis for a class of medications that address conditions like type 2 diabetes and obesity, which are large and growing markets. Advances or investments in GLP-1-based treatments can signal opportunities in healthcare innovation and potentially impact pharmaceutical companies’ growth.
semaglutide medical
"including semaglutide (Ozempic®, Wegovy®), tirzepatide (Mounjaro®, Zepbound®)"
Semaglutide is a medication originally developed to help manage blood sugar levels in people with diabetes, but it also promotes weight loss. It works by mimicking a natural hormone that helps control appetite and insulin release. For investors, its potential to influence healthcare and weight management markets makes it a significant product in the pharmaceutical industry.
tirzepatide medical
"including semaglutide (Ozempic®, Wegovy®), tirzepatide (Mounjaro®, Zepbound®)"
Tirzepatide is a prescription medicine that helps lower blood sugar and reduce appetite by activating two hormones that regulate insulin and hunger; think of it as a two-in-one switch that calms the body’s sugar spikes and decreases cravings. Investors watch it because regulatory approvals, clinical results, pricing and patient demand determine sales potential and competitive impact on companies in diabetes and obesity treatment markets.
liraglutide medical
"and liraglutide (Saxenda®), for weight loss, have significantly influenced"
Liraglutide is a prescription medication that mimics a natural gut hormone to help lower blood sugar and reduce appetite, used for treating type 2 diabetes and for chronic weight management. Investors pay attention because its clinical effectiveness, regulatory approvals, safety profile, patent status and market demand directly affect sales, pricing and competition in the large diabetes and obesity drug markets—think of it as a high-value product whose performance drives revenue and valuation.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

Strong early demand reflects growing consumer interest in protein-rich convenient meals

NEW YORK, July 15, 2026 (GLOBE NEWSWIRE) -- Borealis Foods Inc. (Nasdaq: BRLS), a food science company focused on developing nutritious and accessible food products, today announced the launch of Chef Woo High-Protein Noodles at Costco.

The launch has already generated strong early member demand. “High quality protein-rich foods are in demand across the board. We intend to continue to expand our reach nationally to meet consumer demand. We are encouraged by recent demand forecasts from retailers across the country for our high protein Chef Woo products,” said Reza Soltanzadeh, Founder and Chief Executive Officer of Borealis Foods. “This reflects a broader change in how consumers are thinking about food. As people eat less, they are becoming more thoughtful about the nutritional value they receive from every meal.”

Industry research indicates that increased use of GLP-1 medications, including semaglutide (Ozempic®, Wegovy®), tirzepatide (Mounjaro®, Zepbound®) and liraglutide (Saxenda®), for weight loss, have significantly influenced eating habits, with many consumers placing greater emphasis on protein-rich, nutrient-dense foods.

Borealis Foods believes these changing priorities are contributing to growing interest in its high-protein noodles.

“Chef Woo is well positioned for this evolving marketplace, combining 20 grams of high quality complete protein with all 9 essential amino acids per serving,” Soltanzadeh continued. “Our food science capabilities allow us to respond to changing consumer needs by bringing meaningful nutrition to foods people already know and enjoy.”

About Borealis Foods
Borealis Foods Inc. is an integrated food science and manufacturing company focused on developing nutritious, affordable and sustainable food solutions. The company develops, produces and distributes branded and partner food products through its consumer packaged goods operations.

Its portfolio includes Chef Woo, Ramen Express, Woodles and Chef Ramsay. Chef Woo was created to bring greater nutritional value to the convenience and familiarity of instant noodles.

Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the federal securities laws. Forward-looking statements include statements regarding consumer demand for the Company's products, anticipated retailer demand, purchasing trends associated with GLP-1 medications, the Company's ability to expand distribution, the positioning of Chef Woo in the marketplace, and the Company's growth strategy. These statements are based on current expectations and involve risks and uncertainties that could cause actual results to differ materially, including risks relating to changes in consumer preferences, retailer purchasing decisions, competitive market conditions, supply chain and production factors, the Company's liquidity and financing requirements, its ability to maintain compliance with Nasdaq continued listing requirements, and the other risks described in the Company's filings with the Securities and Exchange Commission. The Company undertakes no obligation to update these statements except as required by applicable law.

Media Contact
Henry Wong
Chief Marketing and Public Relations Officer
Borealis Foods Inc.
1540 Cornwall Road, Suite 104
Oakville, ON L6J 7W5
(905) 278-2200

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/93dae185-1821-47e0-8b60-48eba2b47f66


FAQ

What did Borealis Foods (BRLS) announce about Chef Woo noodles and Costco on July 15, 2026?

Borealis Foods announced the launch of Chef Woo High-Protein Noodles at Costco, reporting strong early member demand. According to Borealis Foods, this expansion supports its goal of making nutritious, accessible, protein-rich meals more widely available to consumers across the United States.

How much protein is in Borealis Foods’ Chef Woo High-Protein Noodles (BRLS)?

Chef Woo High-Protein Noodles contain 20 grams of high-quality complete protein per serving. According to Borealis Foods, each serving also provides all nine essential amino acids, aiming to deliver meaningful nutritional value in a convenient, familiar noodle format.

Why does Borealis Foods (BRLS) see growing demand for its high-protein Chef Woo noodles?

Borealis Foods links growing demand to consumers’ increased focus on protein-rich, nutrient-dense foods. According to Borealis Foods, industry research suggests wider GLP-1 medication use for weight loss is changing eating habits, with shoppers prioritizing higher-protein options like Chef Woo noodles.

How is Borealis Foods (BRLS) responding to changing consumer eating habits in 2026?

Borealis Foods is expanding availability of its high-protein Chef Woo noodles, including at Costco. According to Borealis Foods, its food science capabilities help it adapt products to evolving nutrition priorities as consumers seek more protein and better nutrient density in everyday meals.

What role do GLP-1 weight-loss medications play in Chef Woo noodle demand for BRLS?

Borealis Foods cites research that GLP-1 medications are influencing eating habits and boosting interest in protein-rich foods. According to Borealis Foods, these shifts may be contributing to early strong demand and favorable retailer forecasts for Chef Woo High-Protein Noodles.